Oral Preoperative Carbohydrate on Early Postoperative Outcome After Cesarean Section
- Conditions
- Cesarean Section Complications
- Interventions
- Drug: preoperative carbohydrate loadingDrug: Placebo
- Registration Number
- NCT03732404
- Lead Sponsor
- Aswan University Hospital
- Brief Summary
Preoperative carbohydrate treatments have been widely adopted as part of enhanced recovery after surgery (ERAS) or fast-track surgery protocols. Although fast-track surgery protocols have been widely investigated and have been shown to be associated with improved postoperative outcomes, some individual constituents of these protocols, including preoperative carbohydrate treatment, have not been subject to such robust analysis.
- Detailed Description
Carbohydrate (sugar-containing) nutritional supplements have become a routine part of the package of care for people undergoing planned surgical procedures. the investigator wanted to discover whether carbohydrate supplements are a useful part of care packages used by doctors to improve recovery after planned cesarean section.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 200
- Pregnant women undergoing elective caesarean section
- Term gestational age (37+0 to 41+6 weeks)
- Singleton gestation
- Women with gestational diabetes and diabetes mellitus
- Fetal intrauterine growth restriction
- Ante-natally detected congenital anomaly which will require admission to the neonatal nursery
- Women who received steroids within the past 7 days prior to delivery
- Women who did not complete a gestational diabetes screening test
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description preoperative carbohydrate loading preoperative carbohydrate loading Patients in the treatment group will receive a carbohydrate beverage (total carbohydrates equal to 12.6g/100 mL: 2.1 g monosaccharide, 10.0 g maltodextrin; 240 mOsm/L) in a dose of 800 mL. Patients will be free to drink the beverage from the evening before the operation and up to 2 hours before the induction of anesthesia Placebo Placebo The control group will receive plain water with the same volume and timing of treatment
- Primary Outcome Measures
Name Time Method Length of hospital stay 3 weeks Number of days in the hospital for each participant between the groups.
- Secondary Outcome Measures
Name Time Method Change in preoperative well-being assessment from baseline to one hour using the 100 millimeter (mm) visual analogue scale ist 24 hours postoperative 100 mm visual analogue scales for hunger, thirst, anxiety, fatigue and nausea administered on the morning of surgery prior to morning beverage consumption and 60 minutes after the beverage. All measurements will be assessed using the same scale starting at 0 to 100mm with 0 being the worst and 100 being the best and average being 85.
neonatal blood glucose concentration at four and ten hours of age 24 hours post operative measure neonatal blood glucose level at four and ten hours of age
Neonates with plasma glucose level of less than 45 mg/dL between the groups ist 24 hours postoperative First umbilical cord blood sample will be taken for plasma glucose level of less than 45 mg/dL to note hypoglycemia between the groups.
number of participants experienced nausea 24 hours postoperative Number of participants experienced nausea
Trial Locations
- Locations (1)
Aswan University
🇪🇬Aswan, Egypt